Intravitreal Aflibercept for the Prevention of Proliferative Vitreoretinopathy Following Retinal Detachment Repair

NCT04580147 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Retinal Detachment With Multiple Breaks, Unspecified Eye
Proliferative Vitreoretinopathy

Interventions

DRUG: Intravitreal aflibercept injection
OTHER: Sham control

Sponsor

M. Ali Khan, MD

Collaborators

[object Object]
[object Object]
[object Object]